SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Good-The Bad and The Ugly
MAGS 64.89+0.1%Nov 14 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jane4IceCream who wrote (6890)10/8/2001 2:35:40 PM
From: Tim Luke  Read Replies (1) of 8686
 
jane they will be making it for everyone, here are some news bites:

The company will produce 10 million to 17 million doses a month, according to federal officials. It may continue until enough vaccine exists to immunize all 281 million people in the United States, said federal officials.

"That's the ultimate plan," said Dr. Anthony Fauci of the National Institutes of Health, who will supervise testing of the new vaccine batches. "Not just stop at 30 or 40 million doses, but to at least have the capability that if we need to vaccinate everybody, we can."

Acambis is the only company in the world licensed to make the vaccine. Its US headquarters are in Cambridge, with a lab in Canton. The company does not store infectious strains of the virus, instead refining existing vaccine samples, said company officials. Warehouse locations around the country are tightly guarded secrets.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext